Mevalonate kinase deficiency: an early onset inflammatory bowel disease?

por Martins, A, Berrebi, D, De Lumley, L, Petit, B, Pellegrino, B, Arion, A, Jeanne-Pasquier, C, Lequerre, T, Pellier, I, Guillot, M, Faye, A, Goullet, O, Bader-Meunier, B, Melki, I
Publicado 2015

Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial

por Viallard, J. F., Agape, P., Barlogis, V., Cozon, G., Faure, C., Fouyssac, F., Gaud, C., Gourin, M. P., Hamidou, M., Hoarau, C., Husseini, F., Ojeda-Uribe, M., Pavic, M., Pellier, I., Perlat, A., Schleinitz, N., Slama, B.
Publicado 2016